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Abstract A bioinformatics approach to developing anti-
bodies to specific proteins has been evaluated for the
production of antibodies to heat-processed specified risk
tissues from ruminants (brain and eye tissue). The approach
involved the identification of proteins specific to ruminant
tissues by interrogation of the annotation fields within the
Swissprot database. These protein sequences were then
interrogated for peptide sequences that were unique to the
protein. Peptides were selected that met these criteria as
close as possible and that were also theoretically resistant to
either pepsin or trypsin. The selected peptides were
synthesised and used as immunogens to raise monoclonal
antibodies. Antibodies specific for the synthetic peptides
were raised to half of the selected peptides. These antibodies
have each been incorporated into a competitive enzyme-
linked immunosorbent assay (ELISA) and shown to be able
to detect the heat-processed parent protein after digestion
with either pepsin or trypsin. One antibody, specific for
alpha crystallin peptide (from bovine eye tissue), was able to
detect the peptide in canned meat products spiked with 10%
eye tissue. These results, although preliminary in nature,
show that bioinformatics in conjunction with enzyme
digestion can be used to develop ELISA for proteins in
high-temperature processed foods and demonstrate that the
approach is worth further study.
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Introduction
Since the bovine spongiform encephalopathy (BSE) crisis,
there has been a ban on the presence of certain specified
risk tissues from ruminants entering the human food chain
in order to minimise food-borne exposure risk. These
tissues include tonsils, intestines, mesentery, brains, eyes,
spinal column, trigerminal ganglia, thymus and spleen.
With the fall in the incidence of BSE the EU commission
are reducing BSE control measures,[1] including removing
the maximum age of cattle meat entering the food chain, so
that specified risk material (SRM) testing of meat products
may eventually become the front line in removing SRM
from the food chain.
The detection of specified risk material in food is
currently limited to the detection of central nervous tissues,
e.g. brain and spinal column, and these methods include
direct tissue examination, [2] microscopic examination [3],
immunoassay [4] or gas chromatography detection of brain
cholesterol or specific fatty acids [5, 6]. The immunoassay
procedures have been shown to be effective with only
lightly cooked meat samples [2], and this is also likely to be
the case with more recent methods based on tissue-specific
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mRNA [7] but less so with the methods based on
methylation of tissue-specific DNA promoters [8].
Immunoassays have long been the only reliable method
for the rapid detection of specific proteins in food and
clinical samples, e.g. allergens and bacterial toxins. One of
the main drawbacks of immunoassay is the specificity of
the antibody is limited to the epitopes expressed on the
surface of the protein which imposes limits on the
specificity the antibody can express for a particular protein.
A second drawback to the immunodetection of proteins is
that protein tertiary structure becomes disorganised during
heating, leading to denaturation, precipitation of some
soluble proteins and surface epitopes being hidden in the
core of the denatured protein. It has been postulated for
some time that exposure of the whole protein sequence for
antibody production would significantly improve specificity
of the resulting antibodies and possibly overcome the effect
of heat denaturation. Also, revealing the whole protein
sequence of an antigen could lead to the provision of
antibodies with additional specificity such as tissue or
species specificity since differences in sequence similarity
of the same protein from different species has been used to
predict phylogenic relationships, [9]. The rapid growth of
DNA sequence information and its translation into protein
sequence information has led to the comprehensive public
protein sequence databases at http://www.ncbi.nlm.gov/
collab. A number of tools to interrogate these protein
sequences are freely available on the web, e.g. local
alignment of sequences using Basic Local Alignment Search
Tool (BLAST) (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi),
predicted cleavage sites of protein by proteases (http://www.
expasy.ch/tools/peptidecutter) and the theoretical determina-
tion of the antigenicity of peptide sequences (http://immu
nax.dfci.harvard.edu/Tools/antigenic.pl).
We have proposed that combining these tools could
provide a mechanism to produce theoretical peptide anti-
gens with features that characterise the protein and species
from which the peptide was derived. This could ultimately
lead to the production of species- or tissue-specific anti-
bodies by in silico investigation of protein sequences.
Taking advantage of this opportunity is only hampered by
ensuring the target peptide sequence is not locked in the
core of the protein in a sample matrix and prevented from
binding antibody.
The development of a specific immunoassay based on
this approach would depend on being able to cleave the
proteins in a sample in a predictable and consistent manner
without cleaving the target peptide sequence. Bioinfor-
matics tools are now available which can predict the
cleavage sites of proteases and therefore provide the
theoretical tool to enable selection of the correct protease
to hydrolyse the proteins to peptides in a sample while
retaining the target peptide sequence intact.
This paper therefore reports on an evaluation of this
theoretical approach to develop immunoassays to specified
risk material tissues in canned meat products, opening up
the possibility of designing immunoassays for specific
proteins irrespective of whether the protein has been heat
denatured and specific tissues that can be applied to both
native and severely heat-denatured (canned) protein targets.
Materials and methods
Software tools
The Swissprot protein sequence database (www.expasy.ch/
sprot/) was interrogated to produce a bovine, ovine, caprine
and porcine protein database as well as human and mouse
protein sequence database. A database of tissue-specific
proteins was produced from these by searching the
annotation field within these using the term ‘eye’ or ‘brain’
‘-specific’. The human and mouse protein databases were
similarly searched, and where sequence homology was
found for a particular tissue-specific protein, then this
protein was also added to the database of tissue-specific
(not species-specific) proteins.
The proteins were digested in silico using bespoken in-
house developed software (http://bioinformatics.csl.gov.uk/)
validated against the Expasy peptidecutter program (http://
ca.expasy.org/tools/peptidecutter/) and each of the generated
peptides was then BLAST searched against the Swissprot
database to determine whether the peptide was specific to the
parent protein.
In addition, each protein sequence was cut in silico into
ten overlapping amino acid units, and each ‘10mer’
sequence was BLAST searched against the Swissprot
database to determine which regions of the protein
sequence were specific to that protein. Protein-specific
10mer units were then evaluated using peptidecutter to
determine which were resistant to proteolytic activity.
In-house developed software (http://bioinformatics.csl.
gov.uk/) was used to determine those peptides specific to a
particular protein, which were least likely to be posttransla-
tionally modified and predicted to be an epitope. The
software was capable of determining the most antigenic
regions of the peptides.
Synthesis of peptides
Four of the peptides (peptides 1–4) were synthesised
commercially by Eurogentec S.A (Belgium). The remaining
two peptides (5, 6) were synthesised by Severn Biotech Ltd
(UK). All peptides were synthesised to 75% purity
(Table 1). The ends of the peptides 1,4 and 5 were ‘closed’
by amidation as the synthesised peptide formed the inner
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part of a larger theoretical peptide released by the action of
the selected protease.
Peptides for immunisation
Peptides were obtained as free peptide and also conjugated to
keyhole limpet haemocyanin (KLH) for immunisation using
sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-
carboxylate (sulfo-SMCC). Conjugation to the peptide
was via an additional N-terminal cysteine for all the
peptides except peptide 3 where conjugation was via a C-
terminal cysteine.
Peptides for antibody screening
Selection of the monoclonal antibodies was carried out
using the synthetic peptide conjugated to a carrier other
than KLH.
Peptides 1–4 were conjugated to biotin (by Eurogentec)
via the additional terminal cysteine using sulfosuccinimidyl
6-[3′-(2-pyridyldithio)-propionamido]hexanoate (sulfo-LC-
SPDP) chemistry, while peptides 5 and 6 were conjugated to
bovine serum albumin via the peptide terminal cysteine using
the same chemistry (carried out by Severn Biotech Ltd)
Antibody production
Two female mice (Balb/c Ola Hsd), 10–12 weeks old, were
immunised subcutaneously (sc) with 50 μg of peptide
conjugate in 100 μL of phosphate-buffered saline (PBS)
emulsified with 100 μL of Specol. Booster injections (sc) of
25 μg of peptide conjugate in 100 μL of PBS emulsified with
100 μL of Specol were given at 2-week intervals. The two
mice were primed intraperitoneally with 25 μg of peptide in
200 μL of PBS 4–5 days before spleen cell isolation
Selection of monoclonal antibodies
All culture supernatants were screened using enzyme-linked
immunosorbent assay (ELISA). For antibodies to peptides 5
and 6, plates were coated with the bovine serum albumin
(BSA) peptide conjugate at 5 μg/ml in carbonate buffer pH9.6
overnight at 4°C then washed in PBS and blocked with 5%
milk powder in PBS/0.02% Tween for 2 h at 33°C. Plates
were washed in PBS, then 100 μL tissue culture supernatant,
diluted 1:1,000 in PBS/0.02% Tween/0.2% BSA, was added
to each well. Quantitation of specific antibodywas determined
through the addition of rabbit anti-mouse immunoglobulin G
(IgG)–alkaline phosphatase conjugate.
For peptides 1–4, ELISA plates (Nunc Maxisorp®) were
coated with Neutravidin (Pierce) at 5 μg/mL, then blocked
with fish gelatine and then coated with the biotinylated
peptides at 2 ng/mL in carbonate buffer pH9.6. TissueTa
b
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culture supernatant containing monoclonal antibodies,
diluted 1:1,000 in PBS was added and quantitation of
specific antibody determined through the addition of rabbit
anti-mouse immunoglobulin G (IgG)–horseradish peroxi-
dase conjugate.
For the determination of the 50% inhibition concen-
tration (IC 50) of the synthetic peptides, a competitive
ELISA was developed. Purified antibody and unbound
peptide were added to ELISA plates coated with
biotinylated peptide as described above. Quantitation of
the bound antibody was via the addition of rabbit anti-
mouse IgG horseradish peroxidase or alkaline phospha-
tase conjugate.
All selected monoclonal antibodies (isotype IgG) were
purified on a HiTrap® Protein G column (GE Healthcare)
from their tissue culture supernatants.
Raw materials and reagents
Purified glial fibrillary acidic protein (GFAP; bovine spinal
cord) in 6 M urea and 2 mM dithiothreitol was purchased
from American Research Products (Belmont, MA USA).
Purified alpha crystallin (from bovine eye lens) was
purchased from Sigma (product code C4163).
Brain and eye tissues from cow, pig, sheep and goat
were obtained from the Veterinary Laboratory Agency,
Thirsk, UK.
Canning of meat samples
All heat-processed samples were homogenised as raw tissue
then heat-treated in a canning retort at 121°C for 10 min.
Tissue extracts
Tissue samples were homogenised twice in nine volumes
(w/v) of acetone and the solids recovered by centrifugation
at 2,000×g for 10 min. The solids were then extracted with
two volumes (w/v) of n-butanol by grinding the slurry with
a mortar and pestle. The solid residue was recovered by
centrifugation, washed in hexane and allowed to air dry
before grinding with a mortar and pestle until the powder
passed a 0.1-mm sieve. The sieved powder was stored at
−20°C.
Five millilitre of PBS was added to 0.5 g of the dried
samples and vortexed vigorously for 5 min. Samples were
centrifuged at 2,000×g for 10 min and the supernatant
removed. This supernatant was used in subsequent assays
both in plate-trapped ELISAs and in blotting studies.
Extracts of 13 tissues were prepared for cross-reactivity
studies: Bovine kidney, liver, ileum, spleen and eye;
porcine kidney, liver, ileum, eye and brain; and ovine
ileum, eye and heart.
Proteolytic digestion of samples
Pepsin
One milligram freeze-dried sample (“Tissue extracts” above)
was suspended in 0.966 mL glycine/HCl buffer (0.155 M,
pH1.3), and 4 μL pepsin solution (Sigma Chemical Co.
product P7000; 25 mg/ml in MilliQ water) was added,
mixed carefully and the sample incubated overnight at 37°C
in a shaking water bath. After digestion, 30 μL 5 M sodium
hydroxide was added to stop proteolysis.
Meat samples
One gram meat sample (not dried) was suspended in
8.7 mL glycine/HCl (0.172 M, pH1.3) and 1 mL pepsin
solution added (100 mg/mL in water). Samples were
incubated overnight at 37°C in a shaking water bath. After
digestion, 30 μL of 5 M sodium hydroxide was added to
970 μL digested sample to return the sample to between pH
7 and 8.
Trypsin
Ten milligrams of powdered sample was incubated with
0.4 mL of 25 mM sodium hydroxide for 30 min at 37°C
with shaking. The sample was then adjusted to pH7.5 with
0.1 mL 1 M HCl, and 25 μL 1 M Tris buffer pH7.5, 25 μL
of 2%(w/v) sodium dodecyl sulphate (SDS) and 25 μL of
40 mM tris(2-carboxyethyl)phosphine were then added.
The sample was incubated with shaking for 30 min at
37°C then diluted 1+1 with 200 mM Tris buffer pH8.0
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Fig. 1 Inhibition curves for the eight selected eye-2 monoclonal
antibodies (antibodies inhibited using free eye-2 peptide)
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and 1 mg trypsin (Trypsin Proteomics Grade; T 6567,
Sigma) added and incubated overnight at 37°C with
vigorous shaking. After incubation, the sample was made
2 mM with phenylmethane sulphonyl fluoride in n-
propanol and heated to 100°C for 10 min before
centrifugation to clarify.
Results
Selection of peptides
Two peptides from the sequence of the brain-specific GFAP
protein were identified as likely to be resistant to proteolysis
either by pepsin or trypsin and their sequences shown by
BLAST searching against Swissprot (http://blast.ncbi.nlm.
nih.gov) to be specific to the protein from ruminant species
only (Table 1). Single peptides were also identified from
each of the two brain-specific proteins, glucose transporter
type 3 and neurexin. The sequence of the glucose transporter
3 peptide was also shown through BLAST searching to be
specific to ruminant species. Both peptides were shown to be
likely to be resistant to trypsin cleavage.
Two peptides from the eye-specific proteins alpha
crystallin and filensin were also identified by the in-house
software to be likely antigenic peptides specific for eye
tissue. The filensin peptide was shown by BLAST search-
ing Swissprot to have a sequence specific to ruminant
species; however, the alpha crystallin peptide was shown to
have no species specificity at all.
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using eye-2 antibody and
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in competitive ELISA with
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a competitive ELISA with
plate-trapped peptide
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Antibody characterisation and assay development
No monoclonal antibodies to the target peptides were
identified for three of the peptides, brain-5 peptide, (the
16mer peptide to the brain protein GFAP), brain-3 peptide
(10mer peptide to Glucose transporter type 3) and eye-1
(8mer to filensin).
Eight monoclonal antibodies were isolated for peptide
eye-2. A preliminary screening in competitive ELISA
confirmed the affinity of the antibodies for the target
peptide ranged from ca. 10 ng/mL to ca. 50 μg/mL (Fig. 1)
with no cross-reactivity with the other biotinylated peptides
tested. For subsequent experiments, MAb 6 (61-9A12),
displaying the highest affinity, was selected.
Studies using pepsin on the synthetic peptide confirmed
that the peptide was not digested. In competitive ELISA,
undigested alpha crystallin was not detected by MAb 6, as
opposed to pepsin digested alpha crystallin. This clearly
showed that enzyme digestion was essential for binding of
MAb6 Pepsin digests of bovine, and porcine cooked eye
tissue was also detected by MAb6 (Fig. 2). The IC 50
values for purified alpha crystallin were approximately 1–
2 μg/mL compared with 2 ng/mL for the free peptide. This
was approximately 50 times less sensitive for the protein
digest than the synthetic peptide when compared on a molar
ratio (molecular mass of alpha crystallin 19.7 kDa com-
pared with the molecular mass of the peptide of 1338 Da).
The antibody did not detect pepsin digests of the ten other
tissues used in the-cross reactivity studies.
In tests carried out on canned meat products containing
homogenised eye tissue of different species, the assay
readily detected the addition of 10% eye tissue to the meat
(Fig. 3). In the assay, the meat digests were diluted to a
meat concentration of 10 mg/mL. The difference in
absorbance between the blank and the meat without added
eye tissue indicated some inhibition due to matrix effects
which was assumed to be due to the high protein and fat
concentrations in the extracts. The detection limit of the
developed assay was between 1% and 10% eye.
Six monoclonal antibodies were selected for peptide
brain-4. These were shown not to cross-react with KLH.
Competitive ELISA confirmed the affinity of two of the
antibodies for the synthetic peptide with IC 50 values
calculated at 3.9 and 18.4 μg/mL (Fig. 4). Considering the
molecular mass of the peptide (807 Da) and the molecular
mass of GFAP (54 kDa), the 3.9 μg/mL IC 50 value for the
synthetic peptide corresponds to 256 μg/mL for the whole
GFAP protein. The antibodies were unable to detect native
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Fig. 4 Inhibition curves for the
six selected brain-4 monoclonal
antibodies (antibodies inhibited
using free brain-4 peptide)
0 
0.5 
1 
1.5 
2 
2.5
0.001 0.01 0.1 1 10 100
Protein concentration ug/mL 
A
bs
or
ba
nc
e
pepsin digest 0min 
pepsin digest 1hr 
pepsin digest 15min
pepsin digest 6hr 
pepsin digest 28hr 
free peptide in pepsin buffer
Fig. 5 Effect of pepsin digestion of GFAP on the binding of brain-4
MAb (competitive ELISA)
1850 P. Reece et al.
extracts of bovine brain by immunoblotting but could detect
6 M urea extracts of bovine and porcine brain and GFAP
suggesting the antibody had no species specificity.
Studies using pepsin and trypsin on the synthetic peptide
confirmed that the peptide was not digested by either of
these proteases, and competitive ELISA using pepsin
digests of GFAP showed the digests were detected by the
antibody at high concentrations of GFAP used (50 μg/mL;
Fig. 5) This is in line with the low affinity of the antibodies
for the synthetic peptides, suggesting the antibody had
specificity for the GFAP protein target but with an affinity
corresponding to concentrations higher than were present in
extracts of brain tissue.
Four monoclonal antibodies were isolated for the brain-5
peptide that showed no cross-reactivity with KLH. These
had IC 50 values for the free brain-5 peptide of between 0.1
and 1.0 μg/mL. However, in studies with brain tissue
digests, the antibodies showed no species specificity. A
comparison of the sensitivity of a commercial antibody for
GFAP (supplied by R Biopharm AG) revealed that anti-
bodies to both the brain-4 and brain-5 peptides were
significantly less sensitive towards an SDS extract of
cooked brain tissue than the commercial antibody suggest-
ing these monoclonals had little to offer over the existing
commercial brain tissue-specific antibody.
Discussion and conclusions
The successful production of an ELISA for cooked eye
tissue in canned meat, based on the identification of a short
protease-resistant peptide using bioinformatic tools, has
demonstrated that an in silico approach to generating
immunoassays for cooked proteins is credible. The data
are, however, of a preliminary nature and demonstrate that
the approach is worth being further developed.
The ELISA for the digest of the alpha crystallin
protein was approximately 50-fold less sensitive than for
the synthetic peptide, probably reflecting the degree of
digestion of the parent protein. However in the limited
specificity study, the ELISA was specific to eye tissue,
and therefore, the theoretical approach was valid for
tissue specificity.
The assay in its present form can detect only 1–10% eye
tissue in a canned meat matrix, which is too insensitive to
be of any real commercial value. There is, however,
potential to increase the sensitivity of the assay through
solvent extraction to remove interfering materials as well as
post digestion enrichment of selected peptides using high
throughput solid-phase extraction.
The inability of the approach to produce any species-
specific antibodies could not be explained. None of the
amino acid residues in those sequences that were species
specific were particularly labile and, in the case of the
peptide sequences derived from the brain protein GFAP, the
sequences for a range of animals were in the databases, and
so sequence incompatibility between the species of interest
could be confirmed. Further studies into generating species-
specific peptides is clearly required.
The three peptides that did not lead to the isolation of
specific monoclonal antibodies had nothing particular in
common. Two of these had C-terminal amidation, the same
as peptide brain-4 that resulted in a specific brain
monoclonal antibody with low avidity. The successful
peptide eye-2 antibody had cysteine attached at the N
terminus as did peptides eye-1, -2 and brain-4 and -5
peptides.
In conclusion, this study has shown that the in silico
identification and synthesis of short protease-resistant
peptides, unique to tissue-specific proteins, can be used as
a means of developing immunoassays in conjunction with
protease digestion, for animal tissues in cooked meat, even
after high-temperature processing.
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